The prevalence and morbidity of sensitization to fragrance mix I in the general population.
about
Categorization of fragrance contact allergens for prioritization of preventive measures: clinical and experimental data and consideration of structure-activity relationships.Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets.A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study.Grip strength and lower limb extension power in 19-72-year-old Danish men and women: the Health2006 studyThe association between IGF-I and insulin resistance: a general population study in Danish adultsAllergy to selected cosmetic ingredients.The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part II.The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part III.Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK).Recent trends in epidemiology, sensitization and legal requirements of selected relevant contact allergens.A population-based study of self-reported skin exposures and symptoms in relation to contact allergy in adolescents.Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study.Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study.Was the increase in culture-confirmed Campylobacter infections in Denmark during the 1990s a surveillance artefact?The filaggrin null genotypes R501X and 2282del4 seem not to be associated with psoriasis: results from general population study and meta-analysis.The role of glutathione S-transferase and claudin-1 gene polymorphisms in contact sensitization: a cross-sectional study.Exposures and reactions to allergens among hairdressing apprentices and matched controls.A sensitive method for determination of allergenic fragrance terpene hydroperoxides using liquid chromatography coupled with tandem mass spectrometry.[Clinical epidemiology and prevention of contact allergies. The Information Network of Departments of Dermatology (IVDK) as a register and surveillance system].Psoriasis and the Framingham risk score in a Danish hospital cohort.Association between the Five Factor personality traits and perceived stress: is the effect mediated by general self-efficacy?Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes.Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthood.Contact allergy to the 26 specific fragrance ingredients to be declared on cosmetic products in accordance with the EU cosmetics directive.Characterization of skin sensitizers from autoxidized citronellol - impact of the terpene structure on the autoxidation process.Contact allergy to essential oils cannot always be predicted from allergy to fragrance markers in the baseline series.Contact sensitization to common haptens is associated with atopic dermatitis: new insight.Atopic diseases by filaggrin mutations and birth year.Results of patch testing with fragrance mix 1, fragrance mix 2, and their ingredients, andMyroxylon pereiraeand colophonium, over a 21-year periodThe relationship of glutathione-S-transferases copy number variation and indoor air pollution to symptoms and markers of respiratory diseaseFilaggrin loss-of-function mutation R501X and 2282del4 carrier status is associated with fissured skin on the hands: results from a cross-sectional population studyEstimating the proportion of Danes at high risk of fatal cardiovascular disease
P2860
Q30657458-2390F4C9-9803-41B7-A2B5-2EE93D198105Q34765381-2B8B69F2-E286-475C-BC32-3FEC338AFC06Q35319834-20616577-DE8D-4090-8EE8-1653FB2ED379Q35322623-5A042FDB-2D09-42DC-9A34-FAC98F5E8106Q35841302-AF595D08-9B7D-48F4-8430-BA10DE21946AQ37381934-9257AA52-0E12-4D01-871F-3E5111FB5C41Q37989577-4C8D99A7-8F00-4661-8192-B13B0E6F1DDDQ37989578-26613B2C-F6F4-4D2B-B44D-78A1DA6B0119Q38007971-36A09764-C992-4ABE-A5E8-321F5669B65CQ38632256-E0185942-C6CE-4FB4-98EA-065911F56D42Q38663005-088B3201-FBE5-4463-BFD0-CDD99EA03A83Q40031011-1D400754-D578-4B2B-A2B4-7C2627C90242Q40120045-FE22AF67-7A02-49B1-A779-31F89FE27D23Q40922329-BEBB80E0-3479-422C-8547-0CE5358E8B01Q42600638-2E015D89-2CB8-4144-A41A-B865479100D1Q42714385-2D4177D8-1B5B-4EB6-B61B-45431DC3CDF3Q44815125-A4F0C887-8926-496B-BAC4-DA26CC6877F2Q44978389-8A1FF7D0-B857-4A24-B060-DF171BBFA9FAQ45223330-3DD9CE8A-356C-443E-8625-BCFB51A3A1F4Q45717444-F117A549-E8BB-465C-B7CA-3F0E61DE6648Q46672851-9C249D78-EE96-4736-AEF7-48345C6B50CDQ47677207-C0CDC3FC-6C9A-4151-9265-6407BF663352Q50553496-F5C0B081-51E6-4A28-A038-E3A6850C59F0Q50736596-B6605F18-5D67-433F-B026-62A949481076Q51006296-1D0CFAF6-543C-4502-BF1C-A365A30F1AFCQ52768878-9955D50F-4474-47A9-8FA2-5DF7365752CAQ52842058-24B82220-F394-4EB3-8E1E-B3ADEF94DB67Q53094840-ACF1C871-AD9C-49EC-AEBE-25B306725A97Q53652914-A6A39EE6-54D1-49EB-9DF8-F1D7C69FDCE1Q56690341-7394C9CE-02DF-4437-884A-7D6BE08F9C4BQ57070651-501489B9-B1A6-4C6A-8994-EF8EAE6A958BQ57401969-D340999E-C437-447F-A48D-3768C45032F9Q57730670-349BB96C-16E4-4FD8-9077-5B28CE9DA6D4
P2860
The prevalence and morbidity of sensitization to fragrance mix I in the general population.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The prevalence and morbidity o ...... x I in the general population.
@en
The prevalence and morbidity o ...... x I in the general population.
@nl
type
label
The prevalence and morbidity o ...... x I in the general population.
@en
The prevalence and morbidity o ...... x I in the general population.
@nl
prefLabel
The prevalence and morbidity o ...... x I in the general population.
@en
The prevalence and morbidity o ...... x I in the general population.
@nl
P50
P1476
The prevalence and morbidity o ...... ix I in the general population
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2009.09157.X
P407
P577
2009-04-24T00:00:00Z